This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Illumina Inc. slipped 5.4% to $82.83 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.1% to 5,712.20 and Dow Jones Industrial Average falling 0.3% to 42,454.79.
This was the stock's second consecutive day of losses.
Illumina Inc. closed 47.1% short of its 52-week high of $156.66, which the company achieved on November 5th.
The stock underperformed when compared to some of its competitors, as Labcorp Holdings Inc. fell 0.5% to $233.34, Charles River Laboratories International Inc. fell 1.9% to $158.25, and Quest Diagnostics Inc. rose 0.58% to $166.62.
Trading volume totaled 2.1 million, compared to the 50-day average of 2.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 26, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。